138 related articles for article (PubMed ID: 9802460)
1. Rapid progression of Barrett's esophagus to metastatic esophageal carcinoma in a patient with chronic lymphocytic leukemia.
Hsu CW; Krevsky B; Sigman LM; Thomas RM
J Clin Gastroenterol; 1998 Oct; 27(3):261-4. PubMed ID: 9802460
[TBL] [Abstract][Full Text] [Related]
2. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M
Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128
[TBL] [Abstract][Full Text] [Related]
3. [Surveillance of patients with Barrett's esophagus].
Endlicher E; Knüchel R; Messmann H
Z Gastroenterol; 2001 Aug; 39(8):593-600. PubMed ID: 11558064
[TBL] [Abstract][Full Text] [Related]
4. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
5. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
6. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
Whitson MJ; Falk GW
Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
[TBL] [Abstract][Full Text] [Related]
8. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL
Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
[TBL] [Abstract][Full Text] [Related]
9. Barrett's surveillance identifies patients with early esophageal adenocarcinoma.
Wong T; Tian J; Nagar AB
Am J Med; 2010 May; 123(5):462-7. PubMed ID: 20399324
[TBL] [Abstract][Full Text] [Related]
10. Barrett's esophagus and esophageal cancer.
Streitz JM
Chest Surg Clin N Am; 1994 May; 4(2):227-40. PubMed ID: 8049993
[TBL] [Abstract][Full Text] [Related]
11. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.
Levine DS; Haggitt RC; Blount PL; Rabinovitch PS; Rusch VW; Reid BJ
Gastroenterology; 1993 Jul; 105(1):40-50. PubMed ID: 8514061
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma arising in Barrett's esophagus.
Ovaska J; Miettinen M; Kivilaakso E
Dig Dis Sci; 1989 Sep; 34(9):1336-9. PubMed ID: 2766899
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions.
Reid BJ; Weinstein WM; Lewin KJ; Haggitt RC; VanDeventer G; DenBesten L; Rubin CE
Gastroenterology; 1988 Jan; 94(1):81-90. PubMed ID: 3335302
[TBL] [Abstract][Full Text] [Related]
14. Risk of neoplastic progression in Barrett's esophagus diagnosed as indefinite for dysplasia: a nationwide cohort study.
Kestens C; Leenders M; Offerhaus GJ; van Baal JW; Siersema PD
Endoscopy; 2015 May; 47(5):409-14. PubMed ID: 25521571
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
Wani S; Rubenstein JH; Vieth M; Bergman J
Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
[TBL] [Abstract][Full Text] [Related]
16. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia.
Reid BJ; Blount PL; Feng Z; Levine DS
Am J Gastroenterol; 2000 Nov; 95(11):3089-96. PubMed ID: 11095322
[TBL] [Abstract][Full Text] [Related]
17. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
[TBL] [Abstract][Full Text] [Related]
18. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus.
Geisinger KR; Teot LA; Richter JE
Cancer; 1992 Jan; 69(1):8-16. PubMed ID: 1727677
[TBL] [Abstract][Full Text] [Related]
19. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
Incarbone R; Bonavina L; Bassi F; Peracchia A
Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
[TBL] [Abstract][Full Text] [Related]
20. Chronology of the Barrett's metaplasia-dysplasia-carcinoma sequence.
Theisen J; Nigro JJ; DeMeester TR; Peters JH; Gastal OL; Hagen JA; Hashemi M; Bremner CG
Dis Esophagus; 2004; 17(1):67-70. PubMed ID: 15209744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
